CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals.
Date: June 17, 2019
Source: CutisPharma
Coffee with DistilINFO's Morning Updates...
Sign up for DistilINFO e-Newsletters.
Related Stories
More Than Half of Americans Have Avoided Medical Care Due to Cost
BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada
Health2Sync Partners with DAIKYO ASTAGE and Two Pharmacies to Pilot Health Management Services in Japan
TransCode Therapeutics Announces FDA Authorization to Proceed with First-in-Human Clinical Trial
Livongo Taps MDLive, Doctor on Demand for Virtual Care Integration
GrowGeneration Acquires The Assets Of Reno Hydroponics
Neurotechnology Company Cognito Therapeutics Scores $73M
8 Startups Ahead of the Pulse in Healthcare